col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Wiley: Clinical and Experimental Dermatology
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―22 Induction and exacerbation of subacute cutaneous lupus erythematosus following messenger-RNA or adenoviral-vector based SARS-CoV-2 vaccination A. Kreuter, M.J. Licciardi-Fernandez, S.-N. Burmann, B. Burkert, F. Oellig, A.-L. Michalowitz
2 [GO] 2021―Jul―20 Delayed localized hypersensitivity reactions to COVID-19 mRNA vaccines: A six-month retrospective study I. Papadimitriou, K. Bakirtzi, E. Sotiriou, E. Vakirlis, D. Hatzibougias, D. Ioannides
3 [GO] 2021―Jul―08 Exploring the implications of the first COVID-19 lockdown on patients with melanoma: a national survey S.A. Raza, D. Cannon, G. Nuttall, F.R. Ali
4 [GO] 2021―Jul―08 Vesicolous-bullous skin reactions induced by COVID-19 mRNA vaccine: report of four cases and review of the literature P. Coto-Segura, M. Fernández-Prada, M. Mir-Bonafé, B. García-García, I. González-Iglesias, P. Alonso-Penanes, et al. (+4)
5 [GO] 2021―Jul―08 Vitiligo in a COVID-19 vaccinated patient with ulcerative colitis: A coincidence? H. Aktaş, G. Ertuğrul
6 [GO] 2021―Jun―30 Cutaneous thrombosis associated with skin necrosis following Oxford-AstraZeneca Covid-19 vaccination R. Ramessur, N. Saffar, B. Czako, A. Agarwal, K. Batta
7 [GO] 2021―Jun―11 Every cloud has a silver lining: the environmental benefit of teledermatology during the COVID-19 pandemic G. O’Connell, C. O’Connor, M. Murphy
8 [GO] 2021―Jun―11 Asymmetric cutaneous vasculitis following COVID-19 vaccination with unusual eosinophil preponderance V. Kharkar, T. Vishwanath, S. Mahajan, R. Joshi, P. Gole
9 [GO] 2021―Jun―04 Evaluating the Impact of the COVID-19 Pandemic and State Restrictions on Public Interest in Tanning: A Google Trends Analysis R. Drozdowski, C. Gronbeck, H. Feng
10 [GO] 2021―Jun―03 In-depth, single-centre, analysis of changes in emergency service access after the spread of COVID-19 across Italy T. Ferrari, C. Zengarini, F. Bardazzi, A. Pileri
11 [GO] 2021―Jun―03 Mask induced dermatoses during COVID-19 pandemic: A questionnaire-based study in 12 hospitals of Korea S.Y. Choi, J.Y. Hong, H.J. Kim, G.-Y. Lee, C.S. Hyun, H.J. Jung, et al. (+7)
12 [GO] 2021―Jun―03 Radiation recall dermatitis triggered by inactivated COVID-19 vaccine E. Afacan, B. Öğüt, P. Üstün, E. Şentürk, O. Yazıcı, E. Adışen
13 [GO] 2021―Jun―03 Covid-19 vaccine induced Steven-Johnson syndrome: a case report S. Dash, C.S. Sirka, S. Mishra, P. Viswan
14 [GO] 2021―May―28 Short back and sides: photodermatosis presentation related to hairstyling during the COVID-19 pandemic D.W. Middleton, H.L. Hunter
15 [GO] 2021―May―10 Attendance at an Emergency Dermatology consultation during one year of the COVID-19 pandemic: towards new sensitivities? J. Ortiz-Álvarez, A.J. Durán-Romero, J.C. Hernández-Rodríguez, M. Sendín-Martin, J. Conejo-Mir, J.J. Pereyra Rodriguez
16 [GO] 2021―May―10 COVID-19 vaccine does not trigger psoriasis flares in psoriatic patients treated with apremilast A. Pacifico, A. d’Arino, P.D.M. Pigatto, P. Malagoli, G. Damiani
17 [GO] 2021―Apr―29 A flare of pre-existing erythema multiforme post BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine S. Nawimana, M.J. Lavery, R. Parslew, L. Stewart
18 [GO] 2021―Apr―25 Ivermectin in Dermatology: why it ‘mite’ be useless against COVID-19 D. Roche, C. O’Connor, M. Murphy
19 [GO] 2021―Apr―19 Periorbital Erythema is a Common Cutaneous Manifestation in COVID-19 K. Terzi, S. Kesici, Y. Özsürekci, Benan Bayrakci
20 [GO] 2021―Apr―17 Mohs Micrographic Surgery outcomes following virtual consultations during COVID-19 pandemic P. Nicholson, F.R. Ali, R. Mallipeddi
21 [GO] 2021―Apr―17 Remote consultations for patients with hidradenitis suppurativa during the COVID-19 pandemic: a single centre experience N.P. Patel
22 [GO] 2021―Apr―10 COVID-19 and melanoma surgery in a dermo-oncology center in Italy E. Dika, A. Barisani, C. Baraldi, F. Pepe, A. Patrizi, S. Vaccari
23 [GO] 2021―Apr―09 Ribonucleic acid (RNA) COVID-19 vaccine associated cutaneous adverse drug events: a case series of two patients M. Lam, M. Egail, A.J. Bedlow, S. Tso
24 [GO] 2021―Mar―15 Dietary deprivation during the COVID-19 pandemic producing acquired vulval zinc-deficiency dermatitis M. James, M. Philippidou, M. Duncan, S. Goolamali, T. Basu, S. Walsh
25 [GO] 2021―Mar―05 COVID-19 vaccination and psoriatic patients under biologics: real-life evidence on safety and effectiveness from Italian vaccinated healthcare workers G. Damiani, F. Allocco, P.o Malagoli
26 [GO] 2021―Feb―27 Dermatologists as COVID-19 stigma recipients G. Kyriakou, S. Papanikolaou, C. Bimbi
27 [GO] 2021―Feb―25 Dealing with suspended new routine general dermatology referrals during the COVID-19 pandemic: a virtual model from our local departmental experience A. Pararajasingam, A. Lowe, W. Khan, P. Hancock, N. Stone
28 [GO] 2021―Feb―12 Mask-Related Acne in the COVID-19 Pandemic: An Analysis of Twitter Posts and Influencers R. Drozdowski, C. Gronbeck, H. Feng
29 [GO] 2021―Feb―01 Chilblains and COVID-19: Can recent epidemiological data shed light on the etiological debate? M. Baeck, A. Herman
30 [GO] 2021―Jan―29 COVID-19 induced Toxic Epidermal Necrolysis I. Narang, A.P. Panthagani, M. Lewis, B. Chohan, A. Ferguson, R. Nambi
31 [GO] 2021―Jan―23 Toxic erythema as the first sign of COVID-19 infection M.K. Hunjan, L. Zuzarte, A. Bardhan, S. Karim, A. Heagarty
32 [GO] 2020―Dec―26 The impact of COVID-19 on dermatology outpatient services in England in 2020 L.S. Ibrahim, Z.C. Venables, N.J. Levell
33 [GO] 2020―Nov―29 Sense and sensibility: an Irish dermatology department in the era of COVID-19 C. O’Connor, G. O’Connell, E. Nic Dhonncha, L. Roche, C. Quinlan, L.A. Murphy, et al. (+4)
34 [GO] 2020―Nov―20 Changes in UK dermatological surgery during the COVID-19 pandemic T.M. Tian, V. Ghura
35 [GO] 2020―Nov―18 Skin manifestations of COVID-19 in children: Part 3 D. Andina, A. Belloni-Fortina, C. Bodemer, E. Bonifazi, A. Chiriac, I. Colmenero, et al. (+25)
36 [GO] 2020―Nov―15 Electronic learning for Healthcare (e-LfH) e-Dermatology modules as a key educational tool for trainees during the COVID-19 pandemic: a regional experience F.M. Ali, J. Caesar, M.M.U. Chowdhury
37 [GO] 2020―Nov―12 Skin manifestations of COVID-19 in children: Part 1 D. Andina, A. Belloni-Fortina, C. Bodemer, E. Bonifazi, A. Chiriac, I. Colmenero, et al. (+25)
38 [GO] 2020―Nov―09 Skin manifestations of COVID-19 in children: Part 2 D. Andina, A. Belloni-Fortina, C. Bodemer, E. Bonifazi, A. Chiriac, I. Colmenero, et al. (+25)
39 [GO] 2020―Nov―01 A paradigm shift in trainee confidence in teledermatology and virtual working during the Covid-19 pandemic: results of a follow-up UK-wide survey A. Lowe, A. Pararajasingam, R.G. Goodwin
40 [GO] 2020―Oct―24 An evaluation of dermatology patients shielding during the COVID-19 outbreak S.S. Khan, C.L. Marshall, K.A. Stylianou, E. McMullen, C.E.M. Griffiths, R.B. Warren, H.J.A. Hunter
41 [GO] 2020―Oct―24 “Mask tinea”: tinea faciei possibly potentiated by prolonged mask usage during the COVID-19 pandemic A. Agarwal, T. Hassanandani, A. Das, M. Panda, S. Chakravorty
42 [GO] 2020―Sep―25 Shedding light on the myths of ultraviolet radiation in the Covid-19 pandemic C. O’Connor, C. Courtney, M. Murphy
43 [GO] 2020―Sep―11 Palmar digital vein thrombosis in a COVID-19 patient A. Connolly, S. Walsh, R. Arya
44 [GO] 2020―Aug―28 Patient perceptions of Mohs micrographic surgery during the COVID-19 pandemic and lessons for the next outbreak P. Nicholson, F.R. Ali, R. Patalay, E. Craythorne, R. Mallipeddi
45 [GO] 2020―Aug―16 View from Portsmouth during the COVID-19 pandemic: remote dermatology work A. Haworth
46 [GO] 2020―Aug―05 Reduction in Skin Cancer Diagnoses in the UK during COVID-19 Pandemic T.W. Andrew, M. Alrawi, P. Lovat
47 [GO] 2020―Jul―29 COVID-19 associated herpetic gingivostomatitis T. Kämmerer, J. Walch, M. Flaig, L.E. French
48 [GO] 2020―Jul―29 Teledermoscopy as a community based diagnostic test in the era of Covid-19? A. Lowe, A. Atwan, C.M. Mills
49 [GO] 2020―Jul―24 Irritant contact dermatitis in healthcare workers as a result of the COVID-19 pandemic: a cross-sectional study L.F. Kiely, E. Moloney, G. O’Sullivan, J.A. Eustace, J. Gallagher, J.F. Bourke
50 [GO] 2020―Jul―19 COVID-19: Challenges and solutions for the future of UK dermatology undergraduate curriculum delivery O. Oki, S. Shah, L. Scrivens, J. Guckian
51 [GO] 2020―Jul―08 Immune checkpoint inhibition in the era of COVID-19 J. Kurzhals, P. Terheyden, E.A. Langan
52 [GO] 2020―Jul―06 Mental health and dermatology practice in the COVID-19 pandemic G. Lada, P. S. Talbot, A. Bewley, C. E. Kleyn
53 [GO] 2020―Jul―03 Learning New Ways of Teaching and Assessment - The Impact of Covid-19 on Undergraduate Dermatology Education E. Nic Dhonncha, M. Murphy
54 [GO] 2020―Jul―03 Dermatology residents and COVID-19: life behind the frontlines F. Viviani, T. Ferrari, M. Mussi, C. Zengarini, G. Orioni
55 [GO] 2020―Jul―01 Potential use of Turmeric in COVID-19 H. Gupta, M. Gupta, S. Bhargava
56 [GO] 2020―Jul―01 A UK-wide survey looking at teaching and trainee confidence in teledermatology: A vital gap in a Covid-19 induced era of rapid digital transformation? A. Lowe, A. Pararajasingam, R. Goodwin
57 [GO] 2020―Jun―29 “Cell Phone Acne” Epidemic during COVID-19 Pandemic M. Singh, M. Pawar, A. Maheshwari, A. Bothra, N. Khunger
58 [GO] 2020―Jun―27 Impact of COVID-19 on Mohs micrographic surgery: UK-wide survey and recommendations for practice P. Nicholson, F.R. Ali, R. Mallipeddi
59 [GO] 2020―Jun―23 View from Portsmouth during COVID-19 pandemic ward work A. R. Shipman
60 [GO] 2020―Jun―05 Melanoma defies ‘lockdown’: ongoing detection during Covid-19 in central London A.A. Schauer, E.L. Kulakov, C.L. Martyn-Simmons, C.B. Bunker, E. Edmonds
61 [GO] 2020―Jun―03 Dermatological insights from Google Trends: what does the public think is important during COVID-19 lockdown? T. Searle, F. Al-Niaimi, F.R. Ali
62 [GO] 2020―May―21 Reply to “Clinical and histological characterization of vesicular COVID-19 rashes: a prospective study in a tertiary care hospital”: Pseudoherpetic Grover disease seems to appear in patients with COVID-19 infection M. Llamas-Velasco, P. Chicharro, P. Rodríguez-Jiménez, L. Martos-Cabrera, D. De Argila, M. Fernández-Figueras, J. Fraga
63 [GO] 2020―May―21 Makeshift face shield for healthcare professionals during the COVID-19 pandemic S. Gupta, R. S. Jangra, S. Gupta, A. V. Gujrathi, A. Sharma
64 [GO] 2020―May―18 Novel outbreak of acral lesions in times of COVID-19: A description of 74 cases from a tertiary university hospital in Spain A. Saenz Aguirre, F.J. De la Torre Gomar, P. Rosés-Gibert, J. Gimeno Castillo, Z. Martinez de Lagrán Alvarez de Arcay, R. Gonzalez-Perez
65 [GO] 2020―May―16 A targeted response to the COVID-19 pandemic: analysing effectiveness of remote consultations for triage and management of routine dermatology referrals E. Corden, A. Rogers, W.A. Woo, R. Simmonds, C. Mitchell
66 [GO] 2020―May―14 Cutaneous manifestations in COVID-19: Family cluster of Urticarial Rash R. Cepeda-Valdes, D. Carrion-Alvarez, A. Trejo-Castro, M. Hernandez-Torre, J. Salas-Alanis
67 [GO] 2020―May―09 Erythema multiforme-like eruption in patients with COVID-19 infection: clinical and histological findings J. Jimenez-Cauhe, D. Ortega-Quijano, I. Carretero-Barrio, A. Suarez-Valle, D. Saceda-Corralo, C. Moreno-Garcia del Real, D. Fernandez-Nieto
68 [GO] 2020―May―08 Clinical and histological characterization of vesicular COVID-19 rashes: A prospective study in a tertiary care hospital D. Fernandez-Nieto, D. Ortega-Quijano, J. Jimenez-Cauhe, P. Burgos-Blasco, D. de Perosanz-Lobo, A. Suarez-Valle, et al. (+4)
69 [GO] 2020―May―05 Chilblain-like lesions: a case series of 41 patients during the COVID-19 pandemic J. López-Robles, I. de la Hera, J. Pardo, J. Martínez, E. Cutillas-Marco
70 [GO] 2020―May―05 Observations about sexual and other routes of SARS-CoV-2 transmission and its prevention A.L. Tatu, T. Nadasdy, L.C. Nwabudike
71 [GO] 2020―May―02 Skin signs resembling vascular acrosyndromes during the COVID-19 outbreak in Italy G. Tosti, A. Barisani, P. Queirolo, E. Pennacchioli, L. Villa, A.M. Lodeserto, S. Vaccari
72 [GO] 2020―May―02 Use of transparent curtains on bedside of COVID-19 patients S. Gupta, S. Gupta, A.V. Gujrathi
73 [GO] 2020―May―01 Comment on ‘Two cases of COVID-19 presenting with a clinical picture resembling chilblains: first report from the Middle East’: pernio unrelated to COVID-19 I. Torres-Navarro, C. Abril-Pérez, J. Roca-Ginés, J. Sánchez-Arráez, R. Botella-Estrada, Montserrat Évole-Buselli
74 [GO] 2020―Apr―18 A novel clinical set up for examining healthy dermatology outpatients in time of Covid-19 S. Gupta, R.S. Jangra, A.V. Gujrathi, A. Mahendra, R. Singla, A. Sharma, S. Gupta
75 [GO] 2020―Apr―18 Telemedicine and support groups in order to improve the adherence to treatment and health related quality of life in patients affected by inflammatory skin conditions during COVID-19 emergency C. Marasca, A. Ruggiero, G. Fontanella, M. Ferrillo, G. Fabbrocini, A. Villani
76 [GO] 2020―Apr―18 Screen mirroring, screen casting and screen sharing during COVID-19: What a dermatologist should know D. Jakhar, I. Kaur, S. Kaul
77 [GO] 2020―Apr―17 A case of COVID-19 presenting in clinical picture resembling chilblains disease. First report from the Middle East A. Alramthan, W. Aldaraji
78 [GO] 2020―Apr―03 WhatsApp messenger as a teledermatology tool during coronavirus disease (COVID-19): From Bedside to Phone-side J. Deepak, K. Subuhi, K. Ishmeet


[de][en]

Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.009 sec